(Q34121125)

31 July 2017

1 reference

title

Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients? (English)

1 reference

31 July 2017

1 reference

1 reference

Puoti C

1

1 reference

31 July 2017

Castellacci R

series ordinal

2

1 reference

31 July 2017

Montagnese F

series ordinal

3

1 reference

31 July 2017

language of work or name

1 reference

1 October 2000

1 reference

Digestive and Liver Disease

31 July 2017

1 reference

31 July 2017

32

1 reference

31 July 2017

634-643

1 reference

31 July 2017

7

1 reference

Asymptomatic infection with hepatitis C virus

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Follow up of blood donors positive for antibodies to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Phylogenetic analysis of hepatitis C virus isolates: correlation to viremia, liver function tests, and histology

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

HCV viraemia and liver injury in symptom-free blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Therapy of hepatitis C: patients with normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Diagnosis of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

A retrospective study of hepatitis C virus carriers in a local endemic town in Japan. A possible presence of asymptomatic carrier

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Long-term observation of HCV-positive patients with normal ALT values: persistence of a clinically healthy state

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Circulating HCV-RNA, HCV genotype, and liver histology in asymptomatic individuals reactive for anti-HCV antibody and their follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

High prevalence of antibodies to hepatitis C virus among family members of patients with anti-HCV-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Do symptomless HCV carriers spread infection to their relatives?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Persistent hepatitis C viraemia without liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Do serum ALAT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Alanine aminotransferase measurements and histological disease in hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Detection of plus and minus HCV RNA in normal liver of anti-HCV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Lack of association between type of hepatitis C virus, serum load and severity of liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Genotypic analysis of hepatitis C virus in American patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Levels of hepatitis C virus in blood donors infected with different viral genotypes. International HCV Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

The role of liver biopsy in hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Interferon for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2800%2980850-6

7 January 2021

10.1016/S1590-8658(00)80850-6

Identifiers

DOI

1 reference

31 July 2017

1 reference